155 related articles for article (PubMed ID: 31980731)
21. Transcript variants of RUNX1T1: new insight into t(8;21)-positive leukemia.
Kim JH; Ahn EY
Leuk Res; 2014 Sep; 38(9):1018-9. PubMed ID: 25052308
[No Abstract] [Full Text] [Related]
22. Donor-derived CD19-targeted T cell infusion induces minimal residual disease-negative remission in relapsed B-cell acute lymphoblastic leukaemia with no response to donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation.
Chen Y; Cheng Y; Suo P; Yan C; Wang Y; Chen Y; Han W; Xu L; Zhang X; Liu K; Chang L; Xiao L; Huang X
Br J Haematol; 2017 Nov; 179(4):598-605. PubMed ID: 29076142
[TBL] [Abstract][Full Text] [Related]
23. Sequential treatment with aT19 cells generates memory CAR-T cells and prolongs the lifespan of Raji-B-NDG mice.
Chen R; Wang M; Liu Q; Wu J; Huang W; Li X; Du B; Xu Q; Duan J; Jiao S; Lee HS; Jung NC; Lee JH; Wang Y; Wang Y
Cancer Lett; 2020 Jan; 469():162-172. PubMed ID: 31634527
[TBL] [Abstract][Full Text] [Related]
24. [Chromosome t (8; 21) and t (15; 17) in a patient with acute myeloid leukemia].
Gao Y; Wang C; Xu L; Cao Q; Zhu Y; Cai Q; Yan S; Yang X
Zhonghua Xue Ye Xue Za Zhi; 2001 Feb; 22(2):94-5. PubMed ID: 11877058
[TBL] [Abstract][Full Text] [Related]
25. Antigenic targets of CAR T Cell Therapy. A retrospective view on clinical trials.
Arabi F; Torabi-Rahvar M; Shariati A; Ahmadbeigi N; Naderi M
Exp Cell Res; 2018 Aug; 369(1):1-10. PubMed ID: 29758187
[TBL] [Abstract][Full Text] [Related]
26. CAR T-cell therapy is effective for CD19-dim B-lymphoblastic leukemia but is impacted by prior blinatumomab therapy.
Pillai V; Muralidharan K; Meng W; Bagashev A; Oldridge DA; Rosenthal J; Van Arnam J; Melenhorst JJ; Mohan D; DiNofia AM; Luo M; Cherian S; Fromm JR; Wertheim G; Thomas-Tikhonenko A; Paessler M; June CH; Luning Prak ET; Bhoj VG; Grupp SA; Maude SL; Rheingold SR
Blood Adv; 2019 Nov; 3(22):3539-3549. PubMed ID: 31738832
[TBL] [Abstract][Full Text] [Related]
27. Homoharringtonine, aclarubicin and cytarabine (HAA) regimen as the first course of induction therapy is highly effective for acute myeloid leukemia with t (8;21).
Zhu HH; Jiang H; Jiang Q; Jia JS; Qin YZ; Huang XJ
Leuk Res; 2016 May; 44():40-4. PubMed ID: 26994850
[TBL] [Abstract][Full Text] [Related]
28. Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.
Cai B; Guo M; Wang Y; Zhang Y; Yang J; Guo Y; Dai H; Yu C; Sun Q; Qiao J; Hu K; Zuo H; Dong Z; Zhang Z; Feng M; Li B; Sun Y; Liu T; Liu Z; Wang Y; Huang Y; Yao B; Han W; Ai H
J Hematol Oncol; 2016 Nov; 9(1):131. PubMed ID: 27887660
[TBL] [Abstract][Full Text] [Related]
29. Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.
Rosenbaum L
N Engl J Med; 2017 Oct; 377(14):1313-1315. PubMed ID: 28902570
[No Abstract] [Full Text] [Related]
30. Phenotypic conversion from t(8;21) acute myeloid leukemia to MLL gene rearrangement-positive acute lymphoblastic leukemia.
Ohsaka A; Kato K; Hikiji K
Hematopathol Mol Hematol; 1998; 11(3-4):185-92. PubMed ID: 9844825
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of the AML1-ETO fusion transcript expression in children and young adults with t(8;21) acute myeloid leukemia.
Fleischman EW; Baturina JA; Sokova OI; Popa AV; Kosorukova IS; Rowley JD
Haematologica; 2003 Sep; 88(9):1078-9. PubMed ID: 12969821
[No Abstract] [Full Text] [Related]
32. Acute myeloid leukemia with a novel t(8;21) variant: paracentric inversion-associated ins(21;8).
Lee JH; Wan TS; Ha JS
Leuk Lymphoma; 2014 Feb; 55(2):441-3. PubMed ID: 23672346
[No Abstract] [Full Text] [Related]
33. Time to put the CAR-T before the horse.
Jacobson CA; Ritz J
Blood; 2011 Nov; 118(18):4761-2. PubMed ID: 22053170
[No Abstract] [Full Text] [Related]
34. CAR T cells for infection, autoimmunity and allotransplantation.
Maldini CR; Ellis GI; Riley JL
Nat Rev Immunol; 2018 Oct; 18(10):605-616. PubMed ID: 30046149
[TBL] [Abstract][Full Text] [Related]
35. [An analysis of cytogenetic characteristics and prognosis of 189 t (8; 21) acute myeloid leukemia patients].
Liu XP; Xue YP; Liu SH; Mi YC; Han MZ; Xiao ZJ; Bian SG; Wang JX
Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):918-21. PubMed ID: 17313880
[TBL] [Abstract][Full Text] [Related]
36. Spontaneous remission of infant acute myeloid leukemia with a novel four-way translocation.
Kubo N; Iwabuchi H; Imamura M; Saitoh A; Imai C
Pediatr Blood Cancer; 2020 Feb; 67(2):e28052. PubMed ID: 31724313
[No Abstract] [Full Text] [Related]
37. CD20-CD19 Bispecific CAR T Cells for the Treatment of B-Cell Malignancies.
Martyniszyn A; Krahl AC; André MC; Hombach AA; Abken H
Hum Gene Ther; 2017 Dec; 28(12):1147-1157. PubMed ID: 29207878
[TBL] [Abstract][Full Text] [Related]
38. Adoptive cell therapy for acute myeloid leukemia.
Ma H; Padmanabhan Iyer S; Parmar S; Gong Y
Leuk Lymphoma; 2019 Jun; 60(6):1370-1380. PubMed ID: 30628504
[TBL] [Abstract][Full Text] [Related]
39. [Retrospective analysis of treatment outcomes in 70 patients with t(8;21) acute myeloid leukemia].
Numata A; Fujimaki K; Aoshima T; Onizuka M; Hagihara M; Miyazaki K; Fujita H; Sakai R; Machida S; Tanaka E; Nakajima Y; Hattori Y; Tanaka M; Yamazaki E; Shirasugi Y; Inoue Y; Watanabe S; Fujisawa S
Rinsho Ketsueki; 2012 Jul; 53(7):698-704. PubMed ID: 22975772
[TBL] [Abstract][Full Text] [Related]
40. 8;21 and 15;17 translocations: abnormalities in a single cell lineage in acute myeloid leukemia.
Knuutila S; Majander P; Ruutu T
Acta Haematol; 1994; 92(2):88-90. PubMed ID: 7817709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
